Bloodstream infection (BSI) is a significant complication following allogeneic hematopoietic stem cell transplantation (allo-SCT). Corticosteroids mask inflammatory responses, delaying the initiation of antibiotics. We reviewed medical records of 69 allo-SCT patients who had been on 40.5 mg/kg prednisolone to investigate the efficacy of weekly surveillance blood cultures. A total of 36 patients (52%) had positive cultures, 25 definitive BSI and 11 probable BSI. Pathogens in definitive BSI were Staphylococcus epidermidis (n ¼ 7), S. aureus (n ¼ 4), Entrococcus faecalis (n ¼ 3), Pseudomonas aeruginosa (n ¼ 5), Acenitobacter lwoffii (n ¼ 4), and others (n ¼ 10). The median interval from the initiation of corticosteroids to the first positive cultures was 24 days (range, 1-70). At the first positive cultures, 15 patients with definitive BSI were afebrile. Four of them remained afebrile throughout the period of positive surveillance cultures. Patients with afebrile BSI tended to be older (P ¼ 0.063), and had indwelling central venous catheters less frequently than febrile patients (Po0.0001). Bloodstream pathogens were directly responsible for death in two patients with afebrile BSI. This study demonstrates that cortisosteroid frequently masks inflammatory reactions in allo-SCT recipients given conrticosteroids, and that surveillance blood culture is only diagnostic clue for 'occult' BSI.
Bloodstream infection (BSI) is a significant complication following allogeneic hematopoietic stem cell transplantation (allo-SCT). Corticosteroids mask inflammatory responses, delaying the initiation of antibiotics. We reviewed medical records of 69 allo-SCT patients who had been on 40.5 mg/kg prednisolone to investigate the efficacy of weekly surveillance blood cultures. A total of 36 patients (52%) had positive cultures, 25 definitive BSI and 11 probable BSI. Pathogens in definitive BSI were Staphylococcus epidermidis (n ¼ 7), S. aureus (n ¼ 4), Entrococcus faecalis (n ¼ 3), Pseudomonas aeruginosa (n ¼ 5), Acenitobacter lwoffii (n ¼ 4), and others (n ¼ 10). The median interval from the initiation of corticosteroids to the first positive cultures was 24 days (range, . At the first positive cultures, 15 patients with definitive BSI were afebrile. Four of them remained afebrile throughout the period of positive surveillance cultures. Patients with afebrile BSI tended to be older (P ¼ 0.063), and had indwelling central venous catheters less frequently than febrile patients (Po0.0001). Bloodstream pathogens were directly responsible for death in two patients with afebrile BSI. This study demonstrates that cortisosteroid frequently masks inflammatory reactions in allo-SCT recipients given conrticosteroids, and that surveillance blood culture is only diagnostic clue for 'occult' BSI. Bloodstream infection (BSI) remains a significant complication following allogeneic hematopoietic stem cell transplantation (allo-SCT). The incidence of post transplant BSI has varied from 12.5 to 41%. [1] [2] [3] [4] [5] [6] [7] [8] The frequency of bacterial infection has decreased with the widespread use of antimicrobiotic prophylaxis and empiric administration of broad-spectrum antimicrobiotics. However, better control of Gram negative infections in neutropenic patients has fostered the rise of infections caused by both Gram positive organisms and Gram negative organisms, which are resistant to beta-lactams or fluoroquinolones. These organisms now account for most bacterial infections. 1, [9] [10] [11] [12] Although blood culture is the standard method for obtaining a definitive diagnosis of bacteremia, the usefulness of surveillance blood culture has not been adequately evaluated in patients who are on antibiotic prophylaxis. [13] [14] [15] Serody et al 15 found that blood culture failed to isolate causative organisms in patients developing neutropenic fever while on prophylactic antibiotics. Furthermore, in allo-SCT recipients, inflammatory reactions are frequently absent during neutropenia, and are easily masked by immunosuppressive agents, particularly corticosteroids. Since corticosteroids are commonly used for the prevention and treatment of graft-versus-host-disease (GVHD), asymptomatic bacteremia may be common in the setting of allo-SCT. Few studies reported the benefit of surveillance blood culture. 16 Although a guideline to prevent opportunistic infection among neutropenic patients after allo-SCT has been published, 17 a suitable procedure for the management of infections in asymptomatic patients receiving immunosuppressive therapy remains to be established.
We investigated the frequency and clinical features of subclinical bacteremia in allo-SCT recipients, and evaluated usefulness of surveillance blood culture to diagnose it.
Patients and methods

Patients' characteristics
We reviewed the medical records of 69 patients, who were being treated with 40.5 mg/kg prednisolone following allo-SCT and obtained surveillance blood cultures between August 1998 and August 2002 (Table 1) . Patients with acute myeloblastic leukemia (AML) in first or second remission, acute lymphoblastic leukemia (ALL) in first remission, chronic myelocytic leukemia (CML) in chronic phase, and malignant lymphoma (ML) in second complete or partial remission were classified as standard risk, and others as high risk.
Blood cultures
Surveillance blood cultures were obtained weekly in patients who were given 40.5 mg/kg prednisolone. When patients had central venous catheters, cultures were drawn through these lines. Blood samples were drawn after the skin or catheter hub was swabbed with 10% povidoneiodine. When cultures were positive, they were repeated. We obtained 10 to 20 ml of blood in each culture bottle throughout the study. Culture bottles were incubated until flagged as positive or negative for 7 days in an instrumented blood culture system (BACTEC 9240, Becton Dickinson, Cockeysville, MD, USA) using septic-check biphasic blood media.
Definition
There are no widely used criteria for the diagnosis of BSI in patients receiving corticosteroids. We used the Centers for Disease Control definition of nosocomial infection, 18 referring to the data from Weinstein et al 19 on the probability that isolated microorganisms are actual pathogens. Under immunosuppression, symptoms such as fever, with or without chills, and purulence around an intravascular device are often masked and not reliable for use as criteria. Therefore, only the number of positive blood cultures and the species of the detected organisms are considered to be reliable.
We defined definitive infection as follows:
(a) Common skin contaminants such as diphtheroids, Bacillus spp., Propionibacterium spp., coagulase-negative staphylococci (CNS), and micrococci were cultured in at least two consecutive blood cultures drawn on separate occasions. (b) For rare contaminants such as Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and group B Streptococcus, one positive blood culture was sufficient for a diagnosis of BSI. One positive culture was sufficient for organisms that Weinstein et al 19 reported to be actual pathogens in more than 60% of positive cultures that were obtained from patients without a related infection at any other site.
Control patients were those who had negative blood cultures throughout the immunosuppressive period. Other cases were defined as probable infections. In most cases, the common skin contaminants were cultured only once.
A new infectious episode in afebrile patients was defined as the first positive blood culture, or any positive culture that was drawn 96 h or later after a previous positive culture. Blood cultures positive for different organisms were regarded as separate episodes of BSI when blood samples were drawn on different days. Blood cultures in which multiple organisms grew on the same day were regarded as a single polymicrobial BSI. Response to corticosteroid for GVHD treatment Yes/no 38/20 a We defined acute myeloblastic leukemia in first or second remission, acute lymphoblastic leukemia in first remission, chronic myelocytic leukemia in chronic phase, and malignant lymphoma in first or second complete or partial remission as standard risk, and the others as high risk. b Conventional preparative regimens consisted of cyclophosphamide (CY)/ total body irradiation (TBI) (n ¼ 30), and busulfan (BU)/CY (n ¼ 9); reduced intensity regimens consists of cladribine-based (n ¼ 6), fludarabinebased (n ¼ 21), and fludarabine and low-dose TBI-based regimens (n ¼ 3). c In all, 53 patients had not become neutropenic.
Mortality was considered to be directly attributable to a bloodstream pathogen if the patient died within 7 days after the last positive blood culture without any other probable cause of death. 1 
Clinical management strategy
Patients were managed in reverse isolation in a laminar airflow-equipped room. All patients received oral prophylactic agents: that is, trimethoprim/sulfamethoxazole from day À21 to day À7, and then twice a week after engraftment, and ciprofloxacin 600 mg per day orally for bacterial prophylaxis from the initiation of the conditioning regimen to engraftment. Fluconazole 200 mg was administrated orally as fungal prophylaxis from the initiation of the conditioning regimen to the discontinuation of immunosuppressive agents. Acyclovir 1000 mg per day was given orally from day À7 until day 35, and then given at 400 mg per day until the discontinuation of immunosuppressive agents. 20 Neutropenic fever was managed as previously reported. 21 Briefly, we empirically started beta-lactam antibiotics, and amphotericin B was added at a dose of 0.5 mg/kg/day when the fever persisted for more than 5 days. Neutropenia was defined as neutrophil counts less than 500 per cubic millimeter.
Study design, data collection and statistical analysis
The aims of this study were to (1) determine the frequency of bacterial and fungal infections in allo-SCT recipients who were receiving corticosteroid therapy, (2) identify risk factors for the development of BSI under corticosteroid therapy and (3) evaluate the usefulness of surveillance blood culture in asymptomatic patients on immunosuppressive therapy. Microbiological results were obtained from physicians' medical records, nursing flow sheets, and computerized reports. We collected information including sex, age, complete blood cell counts, body temperature, GVHD grade, antimicrobiotic use, dose of corticosteroids, additional use of other immunosuppressive agents, and day of last follow-up.
Risk factors for BSI were determined by comparing patients with definite evidence of BSI to controls. Risk factors included age, sex, primary disease, preparative regimen, GVHD prophylaxis, HLA-matching, type of donor cycles of chemotherapy prior to transplant, history of bacteremia, insertion of central lines, presence of neutropenia, grade of acute GVHD, presence of chronic GVHD, and initial dose of corticosteroids. These variables were evaluated at the initiation of corticosteroid. Patients with probable BSI were excluded from the analysis of risk factors, since it was unclear whether these patients actually had BSI.
A univariate analysis using the w 2 test and MannWhitney test was performed to evaluate risk factors for BSI. We added a multiple regression analysis to assess the individual contributions of potential predictive factors. For the multivariate analysis, stepwise selection was used to identify the prognostic factors for BSI. The level of significance was set at Po0.05.
Results
Positive blood cultures
We obtained 968 blood samples from 69 patients, with a median of 11 blood cultures (range, 2 to 35) per patient. Of the total 110 positive blood cultures from 36 patients, 86 cultures from 25 patients were definitive BSI. The number of infectious episodes was 40, and 12 patients experienced multiple episodes. One patient developed polymicrobial BSI. Identified microorganisms were 12 bacterial strains from 24 patients and two fungal strains from one patient ( Table 2 ). The microorganisms cultured from blood and catheter tips were identical in three episodes: Staphylococcus epidermidis (n ¼ 2) and S. aureus (n ¼
In all, 15 positive cultures drawn from 11 patients were regarded as probable BSI. Repeated blood cultures after initial positive cultures were negative in 10 patients. A second blood culture was not obtained in the remaining patient because the patient died early of gastrointestinal bleeding due to acute GVHD. Surveillance blood cultures remained negative throughout the study period in the remaining 33 patients. These patients served as a negative control.
Patients' characteristics at the initiation of corticosteroids
Clinical features at the initiation of corticosteroids are shown in Table 3 . Patients with definitive BSI had more profound neutropenia than controls (P ¼ 0.0014). No significant differences in other variables were observed between the two groups.
Characteristics of the first BSI
When the first positive cultures were drawn, 15 of the 25 patients with definitive BSI were afebrile (Table 4) . Four of We defined acute myeloblastic leukemia in first or second remission, acute lymphoblastic leukemia in first remission, chronic myelocytic leukemia in chronic phase, and malignant lymphoma in first or second complete or partial remission as standard risk, and the others as high risk. c Conventional preparative regimens consisted of cyclophosphamide (CY)/ total body irradiation (TBI) (n ¼ 30), and busulfan (BU)/CY (n ¼ 9); reduced intensity regimens consists of cladribine-based (n ¼ 6), fludarabinebased (n ¼ 21), and fludarabine and low-dose TBI-based regimens (n ¼ 3). a These variables were evaluated at the first positive blood cultures. b Two patients who developed documented BSI before engraftment were not included in the analysis of GVHD. c These cocci included S. epidermidis (n ¼ 3), S. aureus (n ¼ 3), and E. faecalis (n ¼ 1). d These included S. epidermidis (n ¼ 2), S. aureus (n ¼ 1), and S. hominis
, and P. mirabilis (n ¼ 1).
f These included P. aeruginosa (n ¼ 3), A. lwoffi (n ¼ 1), and S. maltophilia (n ¼ 1). g C. parapsilosis.
Surveillance blood culture after allo-SCT A Chizuka et al clinical courses. Two presented mild diarrhea. With the initiation of antibiotics and/or removal central lines, diarrhea subsided and the following blood culture became negative. The other patient developed pneumonia, which was successfully treated with antibiotics.
Characteristics and management of recurrent BSI
After the initial BSI episode, 15 recurrent BSI episodes were observed in 12 patients. In all, 10 patients had two BSI episodes each, one had three, and one had four. The median interval between a previous episode and recurrent BSI was 21 days (2-31 days). When BSI recurred, patients were febrile in six episodes and afebrile in nine. The dose of corticosteroids was 0.5-0.9 mg/kg in 11 episodes, 1.0-1.9 mg/kg in three, and X2.0 mg/kg in one. The causative organism was the same as the previous pathogen in five episodes, and included S. aureus (n ¼ 1), Bacteroides sp.
(n ¼ 2), and Pseudomonas aeruginosa (n ¼ 2). In the 15 recurrent BSI episodes, all of the patients received some antimicrobiotics, and the cultured organisms were either sensitive (n ¼ 8) or resistant (n ¼ 4). Susceptibility was not examined in the remaining three episodes.
Mortality
Of the 25 patients with definitive BSI, 15 died during the study period. BSI was directly associated with the death of five patients, to give a mortality rate of 20%. The causative organisms included S. epidermidis, P. aeruginosa, Entrococcus faecalis, Clostridium innocum, and Candida krusei until discharge.
Risk factors of BSI during corticosteroid administration
A univariate analysis showed presence of neutropenia at the initiation of corticosteroid (odds ratio; 
Discussion
The present study showed that BSI remains a common and important problem. It occurred in 25 of 69 (36%) patients. Previous studies identified some predisposing factors for post transplant BSI: mucositis induced by the high-dose preparative regimens, 5 use of central intravenous catheters, 22 presence of GVHD with or without treatment using corticosteroid, 11 and prolonged neutropenia. 23 While all the patients received corticosteroid in this study, most patients were not neutropenic, and mucositis was rarely observed. These findings suggest that use of corticosteroid is a risk factor of BSI even after neutrophil recovery. Since corticosteroid was given for the treatment of GVHD, it is difficult to differentiate the effect of GVHD from that of concomitant use of corticosteroid as a cause of BSI. At present, we can safely mention that patients who receive corticosteroid for the treatment of GVHD are at high-risk of BSI. This study urges us to revise our prophylactic and treatment strategy of bacterial infection in allo-SCT recipients at high risk of bacterial infection.
It is evident that early diagnosis and prompt initiation of aggressive antibacterial treatment is essential to improve prognosis of patients with BSI. However, they are frequently difficult in patients who are given corticosteroid, which masks subjective and objective symptoms associated with BSI. Surveillance blood cultures might be useful for establishing early diagnosis of BSI in these patients. Yet, the usefulness of surveillance blood culture remains in the setting of allo-SCT, in which most patients receive prophylactic antibiotics. While guidelines exist regarding the number and timing of sampling for blood cultures before antibiotic therapy is initiated, 24 they are not established in patients on prophylactic antibiotics. Blood culture rarely isolates causative organisms after initiation of antibiotic therapy. 15, 25 Antibiotics decrease the yield of blood cultures, and routine collection of blood samples may not be helpful in allo-SCT recipients. However, our study revealed a high incidence of 'occult' BSI in these patients. Except for patients' ages and uses of central venous catheters, there were no significant differences in clinical characteristics between an 'occult' BSI and a 'febrile' one. It should be noted that the some patients with definite BSI remained afebrile at the time of blood sampling, and that surveillance blood culture was only diagnostic clue for this complication. Considering that blood stream pathogens were directly responsible for deaths in two patients with 'occult' BSI, surveillance blood culture seemed to be beneficial in making an early diagnosis and initiating aggressive antibacterial treatment.
Concerning the causative organisms, 17, 21, and two of the 40 isolates were Gram positive bacteria, Gram negative bacteria, and fungi, respectively. In Gram positive bacteria, CNS is the most common isolate (seven patients), followed by S. aureus (four patients), and E. faecalis (three patients). One of the seven patients with definite BSI caused by CNS died of bacteremia. These findings indicate that CNS is the most common microorganism isolated from blood cultures in allo-SCT recipients, and that BSI caused by the organism is sometimes fatal. While determining whether there is true bacteremia or merely contamination is a clinical dilemma, it is critical to make an early diagnosis and prompt initiation of appropriate treatments for BSI caused by CNS. It should be noted that removal of inserted catheters is frequently sufficient, because CNS infections are usually related to the long-term central venous indwelling catheters for venous access. 26 Surveillance blood cultures might have contributed to make an early diagnosis of CNS bacteremia and prompt initiation for adequate antibacterial treatment in these patients.
Concerning Gram negative bacteria, five and four patients developed BSI caused by P. aeruginosa and Acenitobacter lwoffii, respectively. Fewer episodes of BSI were caused by these organisms than by CNS, although gastrointestinal involvement of acute GVHD, a risk factor of Gram negative bacteremia following HSCT, was observed in 25 of the 69 patients. Prophylactic use of oral fluoroquinolone might reduce the incidence of Gramnegative bacteremia as reported previously. 27 Alternatively, concomitant antimicrobiotics might have influenced the sensitivity of blood cultures.
14 Compared with S. aureus and streptococci, Gram negative bacilli are less frequently isolated from antimicrobiotic blood cultures. Although the incidence of Gram negative bacteremia was not high in this study, Gram negative bacteremia was fatal in two patients, suggesting that current approaches using fluoroquinolonebased prophylaxis may be insufficient to prevent lifethreatening Gram negative bacteremia.
This study has several limitations, including the fact that this was a retrospective study of patients with heterogeneous backgrounds. In most cases of BSI, the first positive blood cultures were drawn through central venous catheters, and subsequent cultures were obtained by venipuncture. However, we believe that the results are still informative, since little information has been reported to date. BSI is a significant problem in allo-SCT recipients, especially when they are receiving corticosteroid treatment, which masks early signs of inflammatory responses. The data observed in this study support the notion that surveillance blood culture is useful for an early diagnosis of BSI and effective early intervention. Future prospective clinical trials are warranted to confirm this point.
